CELL AND GENE THERAPY INSIGHTS

April 2021 Issue

Volume 7 Issue 4

Cell and Gene Therapy Insights Volume 7 Issue 4
Download PDF

Featuring

Issue Spotlight: Cell therapy CMC and quality control
Supply Chain focus: Ensuring supply chain scalability for cell & gene therapy products
Other articles
Webinar

SPOTLIGHT

Cell therapy CMC and quality control
Christiane Niederlaender
Guest Editor:
Christiane Niederlaender, Vice President Technical

Foreword

Cell therapy CMC and quality control

Cell therapy CMC and quality control

Christiane Niederlaender
13 May 2021
Read

Research Article

Characterization of a novel high-throughput, high-speed and high-precision plate-based image cytometric cell counting method

Characterization of a novel high-throughput, high-speed and high-precision plate-based image cytometric cell counting method

J Bell, Y Huang, H Qazi et al.
14 May 2021
Read

Expert Insight

Addressing sampling challenges in early phase cell therapy manufacturing

Addressing sampling challenges in early phase cell therapy manufacturing

Stephanie Mgebroff
13 May 2021
Read
The role of big data analytics in digitized manufacturing

The role of big data analytics in digitized manufacturing

Damian Marshall, John Churchwell, Marc-Olivier Baradez
13 May 2021
Read

Commentary

Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

L Pierce, S Sarkar, L Li-Ying Chan et al.
14 May 2021
Read
Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

Vilma Jimenez Sabinina, Dominic Günter Hildebrand
13 May 2021
Read

Interview

Bioprocess and analytics priorities for the tissue engineered product and cell therapy fields

Bioprocess and analytics priorities for the tissue engineered product and cell therapy fields

Julie Allickson, PhD
14 May 2021
Read
Unleashing the full power of next gen bioanalytics on cell therapy development

Unleashing the full power of next gen bioanalytics on cell therapy development

Eric Alonzo, PhD
14 May 2021
Read

Expert Roundtable Video

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

27 September 2021
Watch

Expert Roundtable

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Sarah Snykers, Andrea Moore, Tony Bou Kheir
26 September 2021
Read

Supply Chain FOCUS

Ensuring supply chain scalability for cell & gene therapy products

Interview

Building clinical and commercial allogeneic CAR T cell therapy supply chains

Building clinical and commercial allogeneic CAR T cell therapy supply chains

Bob Amareld
28 April 2021
Read

Journal articles

Expert Roundtable Video

Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture

Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture

14 May 2021
Watch

Expert Roundtable

Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture

Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture

U Saplakoglu, T Kotanchek, D Marshall et al.
14 May 2021
Read

Viewpoint

Accelerating the development of novel gene therapies for central nervous system diseases

Accelerating the development of novel gene therapies for central nervous system diseases

Suyash Prasad, MBBS, MSc, MRCP, MRCPCH, FFPM
19 May 2021
Read

Webinars